Want to track 2395 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shin Nippon Biomedical Laboratories Ltd. (2395) Statistics
Valuation metrics
Market Cap 75.89B
Enterprise value 84.45B
Trailing P/E (ttm) 11.4
Forward P/E -
PEG ratio 1.88
Price/Sales (ttm) 1.8
Price/Book (mrq) 1.47
Enterprise Value/Revenue 2.49
Enterprise Value/EBITDA 10.86
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 372.18K
Average volume (90 days) 273.43K
Price summary
52-Week low 1,067
52-Week high 2,005
Beta -
50-Day moving average 1,241.63
200-Day moving average 1,392.01
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 50
Trailing annual dividend yield 0.034%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 2:1
Last split Date 27 Sep 2005
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.16%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 814.67
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 129
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 344.31
Total debt (mrq) -
Total Debt/Equity (mrq) 0.9
Current ratio (mrq) 1.02%
Book value per share (mrq) 1,015.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
